Background: This study aimed to review studies that identified patterns of longitu-
However, these analytical approaches may not be able to completely capture the information available in serial HbA 1c measurements. Specifically, they fail to capture the trajectory of change over time. Existing data suggest that patients with diabetes in the population may have heterogeneous HbA 1c trajectories, 8 and these trajec- clusters individuals based on the trajectories of outcomes. 9, 10 In addition to diabetes, this technique has been applied to various areas of clinical research including physical aggression, cortisol levels, internet usage, obesity, anxiety, depression, 11 crime trends, 12 and psychological disorders. 2 | METHODS
| Literature search
The protocol for this systematic review was registered on PROSPERO, the international prospective register of systematic reviews (unique identification number: CRD 42015019692) and is available in full on the National Institute for Health Research website. 13 This systematic review was conducted in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-analyses statement.
14 PubMed and Web of Science databases were searched for potentially relevant articles from inception of database to September 2017.
The search terms "HbA 1c " or all the Medical Subject Headings terms of HbA 1c combined with "Trajector* OR tracking OR longitudinal profile* OR longitudinal data OR longitudinal level* OR secular trend" were used with no restriction on publication date or languages. The last search was performed in September 2017. Hand searching of citations in included articles for references to other relevant studies was also conducted.
| Study selection and eligibility criteria
Title and abstracts were evaluated to shortlist articles for this review and the eligibility of these articles were confirmed by a full-text review using the following inclusion criteria: (a) longitudinal study of subjects with diabetes only, (b) use of serial measurements of HbA 1c , and (c)
analysis of the trend of HbA 1c using at least one of the group-based trajectory modelling and clustering approaches, 10 including latent class growth analysis, latent class growth mixture model, 2-stage clustering method, k-means cluster analysis, and hierarchical cluster analysis.
Studies that did not meet the inclusion criteria were excluded. 
| Study characteristics
The general information and study characteristics of the 20 included articles are summarized in Table 1 . The studies were ordered by type of diabetes, year of publication, and first author's last name.
All 20 included studies were published in international journals within the recent decade (from 2009 to 2017). The majority of the studies were conducted in the United States (n = 10), followed by Europe (n = 6) and Asia (n = 3), and one study was conducted in Africa.
Fourteen of these studies were prospective cohort studies, 3 were retrospective cohort studies, 1 was an ambispective cohort study, The statistical models used for analysing HbA 1c trajectories included latent class growth analysis (n = 14), latent class growth mixture model (n = 3), 2-stage clustering method (n = 1), k-means cluster analysis (n = 1), and hierarchical cluster analysis (n = 1) ( Table 2 ). The maximum number of clusters evaluated during the model selection was less or equal to 7 in all the studies, and the number of clusters identified in the final model ranged from 2 to 6 (final model: 2 clusters, n = 5; 3 clusters, n = 5; 4 clusters, n = 5; 5 clusters, n = 4; 6 clusters, n = 1).
Bayesian information criterion was the most commonly used tool for FIGURE 1 Flowchart of study selection process Among studies on type 1 diabetes (n = 11), most studies (n = 6) identified a group of patients that maintained stable HbA 1c levels at a low baseline of 7.1% to 7.5%, containing 21% to 69% of the sample.
Another stable trajectory pattern with moderate baseline levels of HbA 1c (7.6%-9.0%) was also frequently observed (n = 6), with the proportion ranging from 17% to 92%. These 2 patterns were usually the largest subgroups in the study population. Three studies also identified a stable pattern at a very low baseline level (6.0%-7.0%), and another 3 studies identified a cluster with continuously poor control with HbA 1c maintained at a moderate high (9.1%-11.0%) or very high baseline level (higher than 11.0%), and each pattern usually contained less than one-third of the sample. Groups with deteriorating HbA 1c , from very low (n = 1), low (n = 1), moderate (n = 7), and moderate-high (n = 3)
baseline HbA 1c , were also identified, with the proportion ranging from 2% to 45%. The group deteriorating from moderate baseline level was most commonly observed in studies. Three studies also identified groups with improving HbA 1c over time, with the proportion ranging from 26% to 32%.
Among studies on type 2 diabetes (n = 9), the most commonly identified pattern was the moderate stable group (n = 7) with a HbA 1c level slightly above the 7.0% target level. This group was usually the largest cluster, containing 15% to 89% of the sample. Two groups with a HbA 1c level below the 7.0% target level and below a more stringent 6.5% level were also identified, ie, low stable (n = 4) and very low stable group (n = 4). The low stable group contained 44% to 83% of the sample, and the very low stable group contained 27% to 48% of the sample. Groups with stable HbA 1c level at a moderately high level (7.1% to 8.0%) were found in 4 studies, with group percentages of 13% to 38%. Two studies identified a small proportion of patients (3% and 15%, respectively) that maintained high HbA 1c levels over time. Groups with deteriorating glycaemic control starting from moderate (n = 2) or moderate-high (n = 4) HbA 1c level were identified in 5 studies, which consisted of 3% to 8% of the sample. Groups with improving control starting from moderate-high (n = 3) or high (n = 6)
baseline HbA 1c level were identified in 6 studies, with group percentage ranging from 2% to 11%. Other non-linear patterns, including U shaped (n = 1), N shaped (n = 3), and L shaped (n = 1), were also observed in a small number of studies. 21 Since the study population comprised mainly children and adolescents, family environment variables including poor family climate or family conflict and parental involvement in care
| Factors and outcomes associated with HbA 1c trajectories
were also found to be associated with poor glycaemic control. Psychosocial variables, including negative emotions and poorer self-control, and onset of puberty were also associated with poorer control. 24 while the other 3 studies found higher BMI was associated with poorer glycaemic control. [25] [26] [27] In addition, Bayliss et al reported that the HbA 1c trajectories did not change significantly before and after the incident co-morbidity of cancer, depression, and pulmonary disease. 28 In terms of outcomes, poor HbA 1c trajectories did not change after incident co-morbidities. 28 It is possible that incident co-morbidities had no significant influence on group trajectories because of the already high co-morbid burden in these patients, with patients having 4 to 5 co-morbid conditions at baseline. We also observed that inconsistent results were reported for the association between BMI and poorer HbA 1c trajectories, with
Chang et al 24 reporting that low BMI was associated with worse trajectories while Walraven et al, 26 Laiteerapong et al, 25 and Luo et al 27 reported the opposite associations. This inconsistency might be due to differences in study population, as the study by Chang et al was conducted among patients with 10-year diabetes duration while the other 3 studies were conducted among patients with newly diagnosed diabetes or patients with an average 4.5 years of diabetes. Obesity was an important risk factor for diabetes and glycaemic control 53 ; however, persistent hyperglycaemia may lead to reduction in weight due to osmotic diuresis and muscle breakdown with excessive gluconeogenesis from amino acid, which might explain the result for the In summary, group-based trajectory analysis identifies subgroups of patients with different natural history of disease. These groups have different characteristics in terms of sociodemographic and disease-related factors. For instance, transition into adulthood 55 and college enrolment 22 have been found to represent vulnerable periods when patients will transition into a period of poor glycaemic control. They also have different outcomes. The groups are finite in number, and many seem to be common across populations studied, suggesting that the pattern of heterogeneity is generalizable to multiple different populations. A better understanding of the psychosocial and biological factors underlying the progression of disease in these groups could lead to the development of targeted strategies to improve outcomes in these patients.
